RAPH1 and breast carcinoma: It has been shown that RAPH1 promotes aggressiveness and radioresistance in breast cancer (Liu Q. et al., 2023) and that high expression of RAPH1 protein is associated with breast cancer shorter survival (Kurozumi et al., 2018).